Tag - vaccinations

 
 

VACCINATIONS

Japan Times
JAPAN
Mar 16, 2022
Japanese municipalities step up preparations for teen booster shots
About 6.8 million — or 75.3% — of people age 12 to 19 have received the initial two doses so far, according to Cabinet Secretariat data.
Japan Times
ASIA PACIFIC
Mar 13, 2022
China fires mayors and closes schools as COVID-19 outbreak spreads
China's National Health Commission announced Saturday that another 1,524 locally transmitted coronavirus cases had been detected in provinces across mainland China.
Japan Times
ASIA PACIFIC
Mar 13, 2022
Shanghai restricts travel as China’s new cases double
While China still has far fewer COVID-19 cases than most countries, the daily count of infections has accelerated rapidly.
Japan Times
WORLD
Mar 12, 2022
WHO exploring when and how to declare end of COVID emergency
Such a declaration would be not just a meaningful symbolic step, and would add momentum to the rollback of many pandemic-era public health policies.
Japan Times
JAPAN
Mar 11, 2022
Israel, Sweden and Chile are recommending a fourth COVID-19 jab. What about Japan?
If fourth doses in Japan are administered six months after third shots, a second booster rollout could begin as early as this summer.
Japan Times
ASIA PACIFIC
Mar 6, 2022
Hong Kong can still achieve COVID-zero, official says
Hong Kong is battling its worst wave yet of COVID-19, which is claiming the lives of at least a hundred people a day.
Japan Times
BASKETBALL / NBA
Feb 24, 2022
Kyrie Irving may be allowed to play at home as New York mulls ending vaccine mandate
Irving has played in road games with the Nets but refused the COVID-19 vaccine required for players in the New York home market.
Japan Times
WORLD
Feb 22, 2022
Got a COVID booster? You probably won’t need another for a long time.
New studies suggest that several parts of the immune system can mount a sustained, potent response to any coronavirus variant.
Japan Times
ASIA PACIFIC / Science & Health
Feb 19, 2022
These vaccines have been embraced by the world. Why not in China?
Two years into the pandemic, China's 1.4 billion people still don't have access to one of the most effective coronavirus vaccines the world has to offer.
Japan Times
COMMENTARY / Japan
Feb 18, 2022
Investments in health systems will protect human security now, and into the future
COVID-19 has exposed the deep inequities and weaknesses in the global health system.
Japan Times
JAPAN
Feb 14, 2022
Workplace booster vaccinations kick off in Japan
ANA and Japan Airlines began administering third doses to staffers in earnest Monday, with more major firms set to join them later this week.
Japan Times
COMMENTARY / World
Feb 11, 2022
Breaking the coronavirus pandemic's grip
There is a significant risk that we will become trapped in an endless cycle of booster vaccinations, chasing the virus rather than getting ahead of it.
Japan Times
WORLD
Feb 10, 2022
The next vaccine debate: Immunize young children now, or wait?
Next week, advisers to the U.S. FDA will decide whether to endorse two doses of the vaccine for children 6 months to 4 years old, before trials have shown the full course to be effective.
Japan Times
COMMENTARY / World
Feb 9, 2022
COVID-19 submerges emerging markets
One reason to be skeptical of the rosy consensus on emerging markets is that COVID-19 has spurred accelerated automation in advanced economies, making them less attractive for manufacturers.
Japan Times
WORLD
Feb 5, 2022
U.S. considers lengthening gap between first two COVID shots to eight weeks
U.S. health officials are considering lengthening the recommended interval to lower the risk of heart inflammation and improve their effectiveness.
Japan Times
WORLD
Feb 1, 2022
COVID’s new divide: risk takers vs. the risk averse
In Italy, with its high vaccination rate, the social schism revolves less around who's gotten a shot, and more around lifestyles and comfort levels of living with the coronavirus.
Japan Times
JAPAN / FOCUS
Feb 1, 2022
Japan scrambles to speed up slowest booster rollout among developed nations
Less than 4% of all residents have received their booster, with the rollout stymied by initial plans for an eight-month shot interval and a seeming preference for Pfizer's vaccine.
Japan Times
WORLD / Science & Health
Feb 1, 2022
How does Merck's COVID-19 pill compare to Pfizer's?
Pfizer said final trial results showed that its treatment reduced the chance of hospitalization or death by 89%, while Merck said their pill reduced those chances by 30%.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?